ID
31953
Description
Study ID: 106181 Clinical Study ID: B2C106181 Study Title: An open-label, single-arm study to determine the excretion balance and metabolic disposition of [14C]GW642444 administered as a single dose of an oral solution to healthy male volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01286831 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: vilanterol Trade Name: Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
Versions (3)
- 10/9/18 10/9/18 -
- 10/10/18 10/10/18 -
- 11/21/18 11/21/18 -
Copyright Holder
GSK group of companies
Uploaded on
October 9, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Extension balance and metabolic disposition of vilanterol as a single oral dose
Study conclusion
- StudyEvent: ODM
Description
Investigator comment log
Description
Only use this form to record explanatory information on anomalies such as missing data, departures from planned investigational product administration or missed visits.
Data type
text
Description
if applicable
Data type
integer
Description
Comment
Data type
text
Description
Investigator's signature
Description
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below
Data type
text
Description
Data type
text
Description
Date
Data type
date
Similar models
Study conclusion
- StudyEvent: ODM